Almi Invest

Almi Invest is a state-owned Swedish venture capital firm and one of the most active early-stage investors in the Nordic region. Operating as part of the Almi group, which provides public-sector financing and advisory services to Swedish small and mid-sized businesses, Almi Invest is positioned to bridge public funding mechanisms and private venture capital. Its healthcare-relevant focus includes medical devices, MedTech, and digital health, alongside a broader mandate spanning life sciences, climate, and broader technology sectors.

The firm concentrates on pre-seed and seed stages, with typical check sizes below $250,000. Geographic activity is concentrated in Sweden, organized through regional offices that source deal flow from across the country. Almi Invest typically co-invests with private venture funds, angel networks, and family offices, contributing public-aligned capital to early rounds and following on through subsequent stages where appropriate. Investments span medical devices, digital health platforms, and broader life sciences tools companies, often emerging from Swedish university research environments or operator-led healthcare teams.

For founders, Almi Invest provides accessible early-stage capital with the credibility of a Swedish state-aligned investor and integration with the wider Almi advisory and lending services. The firm is most relevant to Swedish medical device and digital health companies pursuing both domestic and European commercial markets. Founders should expect a structured diligence process aligned with public-investor governance standards, follow-on participation in subsequent rounds where milestones are met, and engagement focused on early scaling and access to the broader Swedish business ecosystem. The firm is well suited to teams seeking patient, mission-aligned early capital and a credible Nordic institutional anchor for subsequent fundraising.